3-iodobenzylguanidine has been researched along with Cognitive Dysfunction in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishiro, H; Nagahama, Y; Ota, K; Yamagata, M | 1 |
| Ali, T; Allan, L; Barker, S; Barnett, N; Ciafone, J; Colloby, SJ; Donaghy, PC; Durcan, R; Firbank, MJ; Hamilton, CA; Howe, K; Lawley, S; Lloyd, J; O'Brien, J; Petrides, GS; Roberts, G; Taylor, JP; Thomas, AJ | 1 |
| Boccardi, M; Herholz, K; Nobili, F; Picco, A; Ratib, O; Sonni, I; Varrone, A | 1 |
| Ishiura, H; Kurihara, M; Sasaki, T; Tsuji, S | 1 |
| Berg, D; Postuma, RB | 1 |
| Kim, JS; Lee, KS; Oh, YS; Park, HE; Park, JW; Song, IU; Yang, DW | 1 |
| Fujishiro, H; Iseki, E; Kitazawa, M; Nakamura, S; Sato, K | 1 |
2 review(s) available for 3-iodobenzylguanidine and Cognitive Dysfunction
| Article | Year |
|---|---|
Clinical validity of presynaptic dopaminergic imaging withÂ
Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Nortropanes; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2017 |
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders | 2019 |
5 other study(ies) available for 3-iodobenzylguanidine and Cognitive Dysfunction
| Article | Year |
|---|---|
A patient with subjective cognitive decline and recurrent dream-enactment behaviours in a memory clinic: potential diagnostic utility of cardiac
Topics: 3-Iodobenzylguanidine; Cognitive Dysfunction; Humans; Memory; Radionuclide Imaging | 2021 |
Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2021 |
HIV Dementia with a Decreased Cardiac
Topics: 3-Iodobenzylguanidine; AIDS Dementia Complex; Anti-Retroviral Agents; Biomarkers; Cognitive Dysfunction; Fatal Outcome; HIV Infections; Humans; Lewy Bodies; Lewy Body Disease; Male; Middle Aged; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2018 |
(123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Female; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Amnesia; Cognitive Dysfunction; Female; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging | 2012 |